Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 2, 2023
Discovery & Translation

Single-cell T cell atlas identifies new subsets; plus CoRegen’s cell therapy and more

BioCentury’s roundup of translational news
BioCentury | Apr 21, 2016
Distillery Therapeutics

Therapeutics: Nuclear receptor coactivator 3 (NCOA3; SRC3; AIB1)

BioCentury | Mar 10, 2003
Company News

Baylor College of Medicine other research news

BioCentury | Apr 1, 2002
Company News

Harvard Medical School other research news

Items per page:
1 - 6 of 6